Pharma Industry Wraps Up 2024: Lessons Learned and Challenges Ahead
The pharmaceutical industry reflected on its performance in 2024, with several key takeaways. The US Food and Drug Administration approved numerous long-awaited new treatments, including first-in-class medicines. However, the high prices of these new drugs raised concerns about unequal access to healthcare, particularly for low- and middle-income countries. Despite economic headwinds, investors remained cautious and … Read more